SCHEMBL6710078

SCHEMBL6710078

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)COc4ccccc4)c3[nH]2)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
LMNA P02545 5/20 0.37
KDM4E B2RXH2 4/20 0.37
KMT2A Q03164 4/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MEN1 O00255 3/20 0.37
POLB P06746 3/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
GAA P10253 2/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
ADORA3 P0DMS8 3/20 0.36
ADORA2A P29274 3/20 0.36
ADORA2B P29275 2/20 0.36
PLA2G1B P04054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713903 0.95 GAA (0.43) LMNAKDM4EKMT2ANPC1RAB9A
SCHEMBL6709019 0.91 GAA (0.37) LMNAKDM4EPOLBMAPTGAA
SCHEMBL6710103 0.90 ADORA3 (0.37) LMNAPOLBMAPTADORA3ADORA2A
SCHEMBL6709207 0.89 PARP14 (0.43) ALDH1A1LMNAKDM4EGAA
SCHEMBL6708672 0.89 NPC1 (0.46) ALDH1A1LMNANPC1RAB9APOLB
SCHEMBL6714076 0.89 KMT2A (0.41) ALDH1A1LMNAKDM4EKMT2ANPC1
SCHEMBL6708854 0.89 KMT2A (0.42) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL6710395 0.88 PKM (0.35) LMNAPOLBMAPTTHRBRXFP1
SCHEMBL6709008 0.88 MAPT (0.36) ALDH1A1LMNAPOLBMAPTTP53
SCHEMBL6711734 0.88 PARP14 (0.37) ALDH1A1KDM4EPOLBHPGDADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALDH1A1 123/4885LMNA 4062/4885KDM4E 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.